Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AR | P10275 | 9/20 | 0.65 |
| ▸ | MRGPRX4 | Q96LA9 | 2/20 | 0.54 |
| ▸ | TRPV4 | Q9HBA0 | 2/20 | 0.52 |
| ▸ | PDE2A | O00408 | 1/20 | 0.44 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.44 |
| ▸ | SLC22A12 | Q96S37 | 1/20 | 0.43 |
| ▸ | KIF11 | P52732 | 1/20 | 0.42 |
| ▸ | TAS2R14 | Q9NYV8 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1571556 | 0.86 | AR (0.51) | ARMRGPRX4TRPV4SLC22A12TAS2R14 | |
| SCHEMBL384969 | 0.84 | AR (0.47) | ARMRGPRX4PDE2ASLC22A12KIF11 | |
| SCHEMBL29837271 | 0.84 | AR (0.47) | ARMRGPRX4PDE2ASLC22A12KIF11 | |
| SCHEMBL11875183 | 0.82 | AR (0.57) | ARMRGPRX4TRPV4CYP11B2SLC22A12 | |
| SCHEMBL9205171 | 0.81 | CYP11B2 (0.50) | ARCYP11B2 | |
| SCHEMBL12151755 | 0.81 | AR (0.52) | ARCYP11B2KIF11TAS2R14 | |
| SCHEMBL29546917 | 0.81 | AR (0.52) | ARCYP11B2KIF11TAS2R14 | |
| SCHEMBL2555215 | 0.80 | AR (0.65) | ARTRPV4CYP11B2SLC22A12KIF11 | |
| SCHEMBL31568536 | 0.80 | PDE2A (0.44) | ARMRGPRX4PDE2A | |
| SCHEMBL15541043 | 0.80 | PDE2A (0.44) | ARMRGPRX4PDE2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 142 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118184597-A | Preparation method of isoxaflutole | 北京颖泰嘉和生物科技股份有限公司 | 2024-06-14 | — | — | CN | claimed |
| CN-118146127-A | Preparation method of 2-methylthio-4-trifluoromethyl benzonitrile | 北京颖泰嘉和生物科技股份有限公司 | 2024-06-07 | — | — | CN | claimed |
| CN-114149365-B | Process control method for synthesizing 3-cyano-2, 6-dihydroxy-4-trifluoromethyl pyridine triethylamine salt | 江苏中旗科技股份有限公司 | 2024-03-19 | — | — | CN | claimed |
| CN-217120226-U | Production system of isoxazole compound | 内蒙古蓝科生物科技有限公司 | 2022-08-05 | — | — | CN | claimed |
| CN-114149365-A | Process control method for synthesizing 3-cyano-2, 6-dihydroxy-4-trifluoromethylpyridine triethylamine salt | 江苏中旗科技股份有限公司 | 2022-03-08 | — | — | CN | claimed |
| CN-106225213-A | Thermal coupling device control system and control method thereof in a kind of megastore water system | 江苏建筑职业技术学院 | 2016-12-14 | — | — | CN | claimed |
| CN-103087054-A | 4-pyridyl phenyl ether compounds, and preparation method and application thereof | UNIV SHANDONG | 2013-05-08 | — | — | CN | claimed |
| US-20250221979-A1 | NOVEL HETEROCYCLIC COMPOUND | SHOUYAO HOLDINGS BEIJING CO LTD (CN) | 2025-07-10 | — | — | US | disclosed |
| EP-4501912-A1 | NOVEL HETEROCYCLIC COMPOUND | Shouyao Holdings (Beijing) Co., Ltd. (CN) | 2025-02-05 | — | — | EP | disclosed |
| CN-118475560-A | Novel heterocyclic compound | 首药控股(北京)股份有限公司 | 2024-08-09 | — | — | CN | disclosed |
| CN-118184597-A | Preparation method of isoxaflutole | 北京颖泰嘉和生物科技股份有限公司 | 2024-06-14 | — | — | CN | disclosed |
| CN-118184597-A | Preparation method of isoxaflutole | 北京颖泰嘉和生物科技股份有限公司 | 2024-06-14 | — | — | CN | disclosed |
| CN-118146127-A | Preparation method of 2-methylthio-4-trifluoromethyl benzonitrile | 北京颖泰嘉和生物科技股份有限公司 | 2024-06-07 | — | — | CN | disclosed |
| CN-1188476-A | 4-phenylaminothiazole derivatives, method for preparing same, and pharmaceutical compositions thereof | SANOFI SA (FR) | 1998-07-22 | — | — | CN | disclosed |
| EP-0853085-A1 | Piperidine derivatives having anxiolytic effect | H. LUNDBECK A/S (DK) | 1998-07-15 | — | — | EP | disclosed |
| US-5665725-A | Piperidine derivatives having anxiolytic effect | Lundbeck, H. (DK) | 1997-09-09 | — | — | US | disclosed |
| WO-1997024318-A1 | METHOD FOR SYNTHESIS OF AN AROMATIC DERIVATIVE SUBSTITUTED BY A HALOGEN ATOM OTHER THAN FLUORINE AND BY A CYANO GROUP | RHODIA CHIMIE (FR) | 1997-07-10 | — | — | WO | disclosed |
| EP-0593511-A1 | PIPERIDINE DERIVATES HAVING ANXIOLYTIC EFFECT | H. LUNDBECK A/S (DK) | 1994-04-27 | — | — | EP | disclosed |
| WO-1992022554-A1 | PIPERIDINE DERIVATES HAVING ANXIOLYTIC EFFECT | H. LUNDBECK A/S (DK) | 1992-12-23 | — | — | WO | disclosed |
| EP-0518805-A1 | Piperidine derivatives | H. LUNDBECK A/S (DK) | 1992-12-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250221979-A1 | NOVEL HETEROCYCLIC COMPOUND | MAPT, MNAT1, MAT2A | AR 1962/4885MRGPRX4 1140/4885TRPV4 2728/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.